MKKGY (Merck KGaA) Accounts Receivable : $4,133 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Merck KGaA's accounts receivables for the quarter that ended in Dec. 2024 was $4,133 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Merck KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 66.48.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Merck KGaA's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-6.62.

Merck KGaA Accounts Receivable Historical Data

The historical data trend for Merck KGaA's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Accounts Receivable Chart

Merck KGaA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

Get a 7-Day Free Trial

3,918.49

4,119.77

4,358.05

4,366.41

4,132.98

Merck KGaA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Receivable	Get a 7-Day Free Trial															4,366.41	4,507.61	4,588.81	4,426.19	4,132.98

Merck KGaA Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Merck KGaA Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Merck KGaA's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4132.984	/	5673.298	*	91
=	66.48

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Merck KGaA's accounts receivable are only considered to be worth 75% of book value:

Merck KGaA's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(2834.555	+	0.75 * 4132.984	+	0.5 * 4695.288	-	22596.859
-	0	-	78.534)	/	2173.889
=	-6.62

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Merck KGaA Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Accounts Receivable

Traded in Other Exchanges

MKGAF:USA 1MRK:Italy MRKd:UK 0O14:UK MRKC:Germany MRK:Germany MRKC:Germany MRK:Germany MRK:Germany MRK:Germany MRK:Bulgaria MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.